Author correction to ‘Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling’ [Acta Pharmaceutica Sinica B 12 (2022) 1198–1212]
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-07-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383522001629 |
| _version_ | 1811225858553151488 |
|---|---|
| author | Yunhao Wu Xiu Yu Yuwei Wang Yalin Huang Jiahui Tang Shuaishuai Gong Siyu Jiang Yuanli Xia Fang Li Boyang Yu Yuanyuan Zhang Junping Kou |
| author_facet | Yunhao Wu Xiu Yu Yuwei Wang Yalin Huang Jiahui Tang Shuaishuai Gong Siyu Jiang Yuanli Xia Fang Li Boyang Yu Yuanyuan Zhang Junping Kou |
| author_sort | Yunhao Wu |
| collection | DOAJ |
| first_indexed | 2024-04-12T09:14:17Z |
| format | Article |
| id | doaj.art-dcfee2c49c47445a87b41e2187c03ad2 |
| institution | Directory Open Access Journal |
| issn | 2211-3835 |
| language | English |
| last_indexed | 2024-04-12T09:14:17Z |
| publishDate | 2022-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Acta Pharmaceutica Sinica B |
| spelling | doaj.art-dcfee2c49c47445a87b41e2187c03ad22022-12-22T03:38:53ZengElsevierActa Pharmaceutica Sinica B2211-38352022-07-0112731983199Author correction to ‘Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling’ [Acta Pharmaceutica Sinica B 12 (2022) 1198–1212]Yunhao Wu0Xiu Yu1Yuwei Wang2Yalin Huang3Jiahui Tang4Shuaishuai Gong5Siyu Jiang6Yuanli Xia7Fang Li8Boyang Yu9Yuanyuan Zhang10Junping Kou11State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, ChinaState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, ChinaState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, ChinaState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, ChinaState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, ChinaState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, ChinaState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, ChinaState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, ChinaState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, ChinaState Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, ChinaCorresponding authors. Tel./fax: +86 25 86185158.; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, ChinaCorresponding authors. Tel./fax: +86 25 86185158.; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, Chinahttp://www.sciencedirect.com/science/article/pii/S2211383522001629 |
| spellingShingle | Yunhao Wu Xiu Yu Yuwei Wang Yalin Huang Jiahui Tang Shuaishuai Gong Siyu Jiang Yuanli Xia Fang Li Boyang Yu Yuanyuan Zhang Junping Kou Author correction to ‘Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling’ [Acta Pharmaceutica Sinica B 12 (2022) 1198–1212] Acta Pharmaceutica Sinica B |
| title | Author correction to ‘Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling’ [Acta Pharmaceutica Sinica B 12 (2022) 1198–1212] |
| title_full | Author correction to ‘Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling’ [Acta Pharmaceutica Sinica B 12 (2022) 1198–1212] |
| title_fullStr | Author correction to ‘Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling’ [Acta Pharmaceutica Sinica B 12 (2022) 1198–1212] |
| title_full_unstemmed | Author correction to ‘Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling’ [Acta Pharmaceutica Sinica B 12 (2022) 1198–1212] |
| title_short | Author correction to ‘Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling’ [Acta Pharmaceutica Sinica B 12 (2022) 1198–1212] |
| title_sort | author correction to ruscogenin alleviates lps triggered pulmonary endothelial barrier dysfunction through targeting nmmhc iia to modulate tlr4 signaling acta pharmaceutica sinica b 12 2022 1198 1212 |
| url | http://www.sciencedirect.com/science/article/pii/S2211383522001629 |
| work_keys_str_mv | AT yunhaowu authorcorrectiontoruscogeninalleviateslpstriggeredpulmonaryendothelialbarrierdysfunctionthroughtargetingnmmhciiatomodulatetlr4signalingactapharmaceuticasinicab12202211981212 AT xiuyu authorcorrectiontoruscogeninalleviateslpstriggeredpulmonaryendothelialbarrierdysfunctionthroughtargetingnmmhciiatomodulatetlr4signalingactapharmaceuticasinicab12202211981212 AT yuweiwang authorcorrectiontoruscogeninalleviateslpstriggeredpulmonaryendothelialbarrierdysfunctionthroughtargetingnmmhciiatomodulatetlr4signalingactapharmaceuticasinicab12202211981212 AT yalinhuang authorcorrectiontoruscogeninalleviateslpstriggeredpulmonaryendothelialbarrierdysfunctionthroughtargetingnmmhciiatomodulatetlr4signalingactapharmaceuticasinicab12202211981212 AT jiahuitang authorcorrectiontoruscogeninalleviateslpstriggeredpulmonaryendothelialbarrierdysfunctionthroughtargetingnmmhciiatomodulatetlr4signalingactapharmaceuticasinicab12202211981212 AT shuaishuaigong authorcorrectiontoruscogeninalleviateslpstriggeredpulmonaryendothelialbarrierdysfunctionthroughtargetingnmmhciiatomodulatetlr4signalingactapharmaceuticasinicab12202211981212 AT siyujiang authorcorrectiontoruscogeninalleviateslpstriggeredpulmonaryendothelialbarrierdysfunctionthroughtargetingnmmhciiatomodulatetlr4signalingactapharmaceuticasinicab12202211981212 AT yuanlixia authorcorrectiontoruscogeninalleviateslpstriggeredpulmonaryendothelialbarrierdysfunctionthroughtargetingnmmhciiatomodulatetlr4signalingactapharmaceuticasinicab12202211981212 AT fangli authorcorrectiontoruscogeninalleviateslpstriggeredpulmonaryendothelialbarrierdysfunctionthroughtargetingnmmhciiatomodulatetlr4signalingactapharmaceuticasinicab12202211981212 AT boyangyu authorcorrectiontoruscogeninalleviateslpstriggeredpulmonaryendothelialbarrierdysfunctionthroughtargetingnmmhciiatomodulatetlr4signalingactapharmaceuticasinicab12202211981212 AT yuanyuanzhang authorcorrectiontoruscogeninalleviateslpstriggeredpulmonaryendothelialbarrierdysfunctionthroughtargetingnmmhciiatomodulatetlr4signalingactapharmaceuticasinicab12202211981212 AT junpingkou authorcorrectiontoruscogeninalleviateslpstriggeredpulmonaryendothelialbarrierdysfunctionthroughtargetingnmmhciiatomodulatetlr4signalingactapharmaceuticasinicab12202211981212 |